Unknown

Dataset Information

0

Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.

ABSTRACT: We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

SUBMITTER: Petersen MS 

PROVIDER: S-EPMC7588539 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Structures from "Engineering Neutralizing SARS-CoV Antibodies to Bind SARS-CoV-2"
| S-BSST379 | biostudies-other
Unknown Seroprevalence of SARS-CoV-2 antibodies in South Korea.
| S-EPMC8142885 | biostudies-literature
Unknown Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India.
| S-EPMC8270789 | biostudies-literature
Unknown Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
| S-EPMC8059683 | biostudies-literature
Unknown Kinetics and seroprevalence of SARS-CoV-2 antibodies in children.
| S-EPMC7833611 | biostudies-literature
Unknown Seroprevalence of SARS-CoV-2 antibodies among rural healthcare workers.
| S-EPMC8426917 | biostudies-literature
Unknown Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020.
| S-EPMC8014239 | biostudies-literature
Unknown High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
| S-EPMC7499676 | biostudies-literature
Unknown Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional study.
| S-EPMC7657487 | biostudies-literature
Unknown SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands.
| S-EPMC8360234 | biostudies-literature